What is CareDx Inc (CDNA) stock price today?

CareDx Inc (CDNA) currently trades at $20.81 per share. The stock has a market capitalization of $1.09B and a P/E ratio of —x.

Is CDNA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, CareDx Inc has a Smart Value Score of 34/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is CareDx Inc's revenue and earnings?

CareDx Inc has trailing twelve-month (TTM) revenue of $379.81M with profit margins of -5.62%. Earnings per share (EPS) is $-0.40.

Is CDNA stock overvalued or undervalued?

Based on our DCF model, CareDx Inc's intrinsic value is $53.80, representing a margin of safety of 63.35%. The stock currently trades at a P/E of —x.

CDNA

CareDx Inc

NASDAQ: CDNA · HEALTHCARE · DIAGNOSTICS & RESEARCH

$20.81

+0.05% today

Updated 2026-04-30

Market cap

$1.09B

P/E ratio

—

P/S ratio

2.86x

EPS (TTM)

$-0.40

Dividend yield

—

52W range

$11 – $23

Volume

0.7M

Market cap

$1.09B

P/E ratio

—

P/S ratio

2.86x

EPS (TTM)

$-0.40

Dividend yield

—

52W range

$11 – $23

Volume

0.7M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

6.0

Growth

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$24.80

+19.17%

12-Month target

—

Intrinsic (DCF)

$53.80

Margin of safety

+63.35%

0 Strong Buy3 Buy5 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $514000.00 — positive

+ Revenue growth 25.20% QoQ

+ 63.35% below intrinsic value

Risks

- Thin margins at -5.62%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$321.79M	$280.32M	$333.79M	$379.81M	$379.81M
Net income	$-76.61M	$-190.28M	$52.55M	$-21.35M	$2.81M
EPS	—	—	—	—	$-0.40
Free cash flow	$-49.57M	$-27.63M	$31.56M	$36.12M	$514000.00
Profit margin	-23.81%	-67.88%	15.74%	-5.62%	-5.62%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-04-06	NOVACK, JEFFREY ADAM	Sale	1,892	$17.82
2026-04-02	GOLDBERG, MICHAEL	Buy	1,981	—
2026-04-01	NOVACK, JEFFREY ADAM	Sale	3,987	$17.87

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CDNA	$1.09B	34	6.0	2.0	6.7	5.0	+63.35%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

CareDx Inc trades at $20.81. Our Smart Value Score of 34/100 indicates the stock is weak. TTM revenue stands at $379.81M. with profit margins at -5.62%. Our DCF model estimates intrinsic value at $53.80.

Frequently asked questions

What is CareDx Inc's stock price?

CareDx Inc (CDNA) trades at $20.81.

Is CareDx Inc overvalued?

Smart Value Score 34/100 (Grade F, Strong Sell). DCF value $53.80.

What is the price target of CareDx Inc (CDNA)?

The analyst target price is $24.80, representing +19.2% upside from the current price of $20.81.

What is the intrinsic value of CareDx Inc (CDNA)?

Based on our DCF model, intrinsic value is $53.80, a +63.4% margin of safety versus $20.81.

What is CareDx Inc's revenue?

TTM revenue is $379.81M.

Company info

SectorHEALTHCARE

IndustryDIAGNOSTICS & RESEARCH

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2.86x

ROE-6.27%

Beta2.54

50D MA$18.40

200D MA$16.73

Shares out0.05B

Float0.05B

Short ratio—

Avg volume0.7M

Performance

1 week+39.69%

1 month+29.00%

3 months+12.04%

YTD+19.00%

1 year—

3 years—

5 years—

Compare

CDNA vs LLY →CDNA vs JNJ →CDNA vs ABBV →Stock screener →